Gut Microbiota Modulation in Hypertension Management

Summary

Emerging evidence has established the gut microbiota as a dynamic regulator of host blood pressure, acting through a complex interplay of microbial metabolites, immune modulation and neurohumoral pathways. Shifts in the composition and functional capacity of intestinal microbes—often termed dysbiosis—have been linked to both the onset and progression of hypertension. Key microbial products such as short-chain fatty acids (SCFAs), bile acids and trimethylamine N-oxide (TMAO) influence vascular tone, sodium homeostasis and inflammatory signalling. Conversely, antihypertensive agents including angiotensin receptor blockers can reshape microbial communities, creating a bidirectional drug-microbiome axis. Dietary interventions, probiotics, prebiotics and faecal microbiota transplantation represent promising strategies to restore microbial equilibrium, reduce systemic inflammation and improve endothelial function. Preclinical and clinical studies highlight the potential of microbiota-targeted therapies to complement existing pharmacological approaches, offering personalised avenues to mitigate cardiovascular risk on a global scale.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Gut Microbiota Modulation in Hypertension Management publication trend

The graph below shows the total number of articles in gut microbiota modulation in hypertension management across all publications each year (not limited to Nature Index journals).

Technical terms

Gut microbiota: The ensemble of bacteria, archaea, viruses and fungi inhabiting the gastrointestinal tract, collectively influencing host physiology.

Dysbiosis: A maladaptive shift in microbial composition or function that disrupts homeostasis and may contribute to disease.

Short-chain fatty acids (SCFAs): Key bacterial fermentation products (such as acetate, propionate and butyrate) that modulate vascular and immune responses.

Faecal microbiota transplantation (FMT): The transfer of processed stool from a healthy donor into the intestinal tract of a recipient to restore microbial balance.

α-diversity: A measure of species richness and evenness within a single microbial community.

β-diversity: A metric of compositional variation between different microbial communities.

References

  1. Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages. iMeta (2024).
  2. Influence of angiotensin II on the gut microbiome: modest effects in comparison to experimental factors. Cardiovascular Research (2024).
  3. Untapped potential of gut microbiome for hypertension management. Gut Microbes (2024).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.